MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, WVE had $300,036K increase in cash & cash equivalents over the period. -$188,211K in free cash flow.

Cash Flow Overview

Change in Cash
$300,036K
Free Cash flow
-$188,211K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of ordina...
    • Proceeds from issuance of ordina...
    • Proceeds from issuance pre-funde...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Deferred revenue
    • Operating lease liabilities
    • Others

Cash Flow
2025-12-31
Net loss
-204,378
Amortization of right-of-use assets
5,412
Depreciation of property and equipment
3,440
Share-based compensation expense
24,973
Accounts receivable
-146
Prepaid expenses
-1,149
Other assets
-4,314
Accounts payable
-561
Accrued expenses and other current liabilities
5,483
Deferred revenue
-19,833
Operating lease liabilities
-7,638
Other non-current liabilities
0
Net cash used in operating activities
-187,493
Purchases of property and equipment
718
Net cash used in investing activities
-718
Proceeds from issuance of ordinary shares-December Two Thousand Twenty Five Offering
330,912
Proceeds from issuance pre-funded warrants, net of offering costs-December Two Thousand Twenty Five Offering
46,938
Proceeds from issuance of ordinary shares pursuant to the at-the-market equity program, net
94,636
Proceeds from the exercise of share options
14,868
Proceeds from the espp
881
Net cash provided by financing activities
488,235
Effect of foreign exchange rates on cash
12
Net increase in cash, cash equivalents and restricted cash
300,036
Cash, cash equivalents and restricted cash, beginning of period
305,838
Cash, cash equivalents and restricted cash, end of period
605,874
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofordinary...$330,912K Proceeds from issuance ofordinary shares pursuant...$94,636K Proceeds from issuancepre-funded warrants, net of...$46,938K Proceeds from theexercise of share options$14,868K Proceeds from the espp$881K Net cash provided byfinancing activities$488,235K Effect of foreignexchange rates on cash$12K Net increase incash, cash...$300,036K Canceled cashflow$188,211K Share-based compensationexpense$24,973K Accrued expenses andother current...$5,483K Amortization of right-of-useassets$5,412K Other assets-$4,314K Depreciation of property andequipment$3,440K Prepaid expenses-$1,149K Accounts receivable-$146K Net cash used inoperating activities-$187,493K Net cash used ininvesting activities-$718K Canceled cashflow$44,917K Net loss-$204,378K Purchases of property andequipment$718K Deferred revenue-$19,833K Operating leaseliabilities-$7,638K Accounts payable-$561K

Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ltd. (WVE)